SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 6,818.84 |
Enterprise Value ($M) | 6,555.84 |
Book Value ($M) | 2,263.91 |
Book Value / Share | 7.47 |
Price / Book | 3.01 |
NCAV ($M) | 639.51 |
NCAV / Share | 2.11 |
Price / NCAV | 10.66 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.08 |
Return on Assets (ROA) | 0.07 |
Return on Equity (ROE) | 0.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.30 |
Current Ratio | 3.34 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,317.96 |
Assets | 2,942.36 |
Liabilities | 678.45 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1,830.21 |
Operating Income | 170.88 |
Net Income | 207.76 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 333.32 |
Cash from Investing | -26.95 |
Cash from Financing | -546.05 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Renaissance Technologies Llc | 5.16 | 4.38 | |
13G/A | Vanguard Group Inc | 10.18 | -1.91 | |
13G/A | BlackRock Inc. | 11.60 | 4.30 | |
13D/A | Caligan Partners LP | 0.28 | 7.14 | |
13D/A | Farallon Capital Partners, L.P. | 7.90 | 10.20 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
363,583 | 1,899,882 | 19.14 | |
630,970 | 2,125,957 | 29.68 | |
337,561 | 2,293,305 | 14.72 | |
202,749 | 820,226 | 24.72 | |
175,262 | 783,329 | 22.37 | |
(click for more detail) |
Similar Companies | |
---|---|
ENTA – Enanta Pharmaceuticals, Inc. | ERAS – Erasca, Inc. |
EWTX – Edgewise Therapeutics, Inc. | FDMT – 4D Molecular Therapeutics, Inc. |
FGEN – FibroGen, Inc. |